During the past decade, McLaren Cancer Institute-Clarkston conducted 41 clinical trials. In the 10-year time frame, 41 clinical trials started and 10 clinical trials were completed, i.e. on average, 24.4% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 9 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "McLaren Cancer Institute-Clarkston" #1 sponsor was "National Cancer Institute (NCI)" with 21 trials, followed by "NRG Oncology" with 10 trials sponsored, "Alliance for Clinical Trials in Oncology" with 6 trials sponsored, "SWOG Cancer Research Network" with 6 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 6 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "McLaren Cancer Institute-Clarkston" #1 collaborator was "National Cancer Institute (NCI)" with 28 trials as a collaborator, "NRG Oncology" with 10 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "McLaren Cancer Institute-Clarkston" are "Invasive Breast Carcinoma" (4 trials), "Colon Adenocarcinoma" (3 trials), "Estrogen Receptor Negative" (3 trials), "HER2/Neu Negative" (3 trials) and "Progesterone Receptor Negative" (3 trials). Many other conditions were trialed in "McLaren Cancer Institute-Clarkston" in a lesser frequency.

Most popular intervention types in "McLaren Cancer Institute-Clarkston" are "Drug" (36 trials), "Other" (34 trials), "Radiation" (21 trials), "Biological" (17 trials) and "Procedure" (10 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (21 trials), "Laboratory Biomarker Analysis" (16 trials), "Questionnaire Administration" (12 trials), "Intensity-Modulated Radiation Therapy" (9 trials) and "Cisplatin" (8 trials). Other intervention names were less common.

The vast majority of trials in "McLaren Cancer Institute-Clarkston" are 38 trials for "All" genders, 7 trials for "Male" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "McLaren Cancer Institute-Clarkston". undefined are not yet recruiting, 14 are recruiting, 30 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in McLaren Cancer Institute-Clarkston, 3 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in McLaren Cancer Institute-Clarkston, 1 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 36 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".